March 28, 2011
Novalar Pharmaceuticals has entered into an agreement to sell its OraVerse injection drug to a dental pharmaceutical company. The product rapidly reverses lingering lip and tongue numbness that results from local dental anesthesia.
Stories this photo appears in:
PHARMACEUTICALS: Novalar Sells FDA-Approved Product
After finding a buyer for its only product, local dental biotech company Novalar Pharmaceuticals Inc. will cease operations at the end of the month.